CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1. Increasing incidence of muscle and tendon disorder and sports-related injuries
3.4.1.2. Rise in technological advancement
3.4.1.3. Rise in chronic and musculoskeletal disorder
3.4.2.Restraints
3.4.2.1. High cost of the treatment
3.4.3.Opportunities
3.4.3.1. High growth potential in developing economies
3.5.COVID-19 Impact Analysis on the market
CHAPTER 4: SHOCKWAVE THERAPY MARKET, BY TECHNIQUE
4.1 Overview
4.1.1 Market size and forecast
4.2. Electrohydraulic Technique
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3. Piezoelectric Technique
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.4. Radial Technique
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country
4.5. Electromagnetic Shock Waves
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market share analysis by country
CHAPTER 5: SHOCKWAVE THERAPY MARKET, BY PRODUCT
5.1 Overview
5.1.1 Market size and forecast
5.2. Mobile Shockwave Therapy Devices
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3. Fixed Shockwave Therapy Devices
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: SHOCKWAVE THERAPY MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2. Orthopedics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3. Cardiology
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.4. Urology
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market share analysis by country
6.5. Others
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market share analysis by country
CHAPTER 7: SHOCKWAVE THERAPY MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2. Hospitals
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market share analysis by country
7.3. Clinics
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market share analysis by country
7.4. Others
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market share analysis by country
CHAPTER 8: SHOCKWAVE THERAPY MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Technique
8.2.3 North America Market size and forecast, by Product
8.2.4 North America Market size and forecast, by Application
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Key market trends, growth factors and opportunities
8.2.6.1.2 Market size and forecast, by Technique
8.2.6.1.3 Market size and forecast, by Product
8.2.6.1.4 Market size and forecast, by Application
8.2.6.1.5 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Key market trends, growth factors and opportunities
8.2.6.2.2 Market size and forecast, by Technique
8.2.6.2.3 Market size and forecast, by Product
8.2.6.2.4 Market size and forecast, by Application
8.2.6.2.5 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Key market trends, growth factors and opportunities
8.2.6.3.2 Market size and forecast, by Technique
8.2.6.3.3 Market size and forecast, by Product
8.2.6.3.4 Market size and forecast, by Application
8.2.6.3.5 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Technique
8.3.3 Europe Market size and forecast, by Product
8.3.4 Europe Market size and forecast, by Application
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Key market trends, growth factors and opportunities
8.3.6.1.2 Market size and forecast, by Technique
8.3.6.1.3 Market size and forecast, by Product
8.3.6.1.4 Market size and forecast, by Application
8.3.6.1.5 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Key market trends, growth factors and opportunities
8.3.6.2.2 Market size and forecast, by Technique
8.3.6.2.3 Market size and forecast, by Product
8.3.6.2.4 Market size and forecast, by Application
8.3.6.2.5 Market size and forecast, by End User
8.3.6.3 UK
8.3.6.3.1 Key market trends, growth factors and opportunities
8.3.6.3.2 Market size and forecast, by Technique
8.3.6.3.3 Market size and forecast, by Product
8.3.6.3.4 Market size and forecast, by Application
8.3.6.3.5 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Key market trends, growth factors and opportunities
8.3.6.4.2 Market size and forecast, by Technique
8.3.6.4.3 Market size and forecast, by Product
8.3.6.4.4 Market size and forecast, by Application
8.3.6.4.5 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Key market trends, growth factors and opportunities
8.3.6.5.2 Market size and forecast, by Technique
8.3.6.5.3 Market size and forecast, by Product
8.3.6.5.4 Market size and forecast, by Application
8.3.6.5.5 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Key market trends, growth factors and opportunities
8.3.6.6.2 Market size and forecast, by Technique
8.3.6.6.3 Market size and forecast, by Product
8.3.6.6.4 Market size and forecast, by Application
8.3.6.6.5 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Technique
8.4.3 Asia-Pacific Market size and forecast, by Product
8.4.4 Asia-Pacific Market size and forecast, by Application
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Key market trends, growth factors and opportunities
8.4.6.1.2 Market size and forecast, by Technique
8.4.6.1.3 Market size and forecast, by Product
8.4.6.1.4 Market size and forecast, by Application
8.4.6.1.5 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Key market trends, growth factors and opportunities
8.4.6.2.2 Market size and forecast, by Technique
8.4.6.2.3 Market size and forecast, by Product
8.4.6.2.4 Market size and forecast, by Application
8.4.6.2.5 Market size and forecast, by End User
8.4.6.3 Australia
8.4.6.3.1 Key market trends, growth factors and opportunities
8.4.6.3.2 Market size and forecast, by Technique
8.4.6.3.3 Market size and forecast, by Product
8.4.6.3.4 Market size and forecast, by Application
8.4.6.3.5 Market size and forecast, by End User
8.4.6.4 India
8.4.6.4.1 Key market trends, growth factors and opportunities
8.4.6.4.2 Market size and forecast, by Technique
8.4.6.4.3 Market size and forecast, by Product
8.4.6.4.4 Market size and forecast, by Application
8.4.6.4.5 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Key market trends, growth factors and opportunities
8.4.6.5.2 Market size and forecast, by Technique
8.4.6.5.3 Market size and forecast, by Product
8.4.6.5.4 Market size and forecast, by Application
8.4.6.5.5 Market size and forecast, by End User
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Key market trends, growth factors and opportunities
8.4.6.6.2 Market size and forecast, by Technique
8.4.6.6.3 Market size and forecast, by Product
8.4.6.6.4 Market size and forecast, by Application
8.4.6.6.5 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Technique
8.5.3 LAMEA Market size and forecast, by Product
8.5.4 LAMEA Market size and forecast, by Application
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Key market trends, growth factors and opportunities
8.5.6.1.2 Market size and forecast, by Technique
8.5.6.1.3 Market size and forecast, by Product
8.5.6.1.4 Market size and forecast, by Application
8.5.6.1.5 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Key market trends, growth factors and opportunities
8.5.6.2.2 Market size and forecast, by Technique
8.5.6.2.3 Market size and forecast, by Product
8.5.6.2.4 Market size and forecast, by Application
8.5.6.2.5 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Key market trends, growth factors and opportunities
8.5.6.3.2 Market size and forecast, by Technique
8.5.6.3.3 Market size and forecast, by Product
8.5.6.3.4 Market size and forecast, by Application
8.5.6.3.5 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Key market trends, growth factors and opportunities
8.5.6.4.2 Market size and forecast, by Technique
8.5.6.4.3 Market size and forecast, by Product
8.5.6.4.4 Market size and forecast, by Application
8.5.6.4.5 Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2021
CHAPTER 10: COMPANY PROFILES
10.1 EDAP TMS
10.1.1 Company overview
10.1.2 Key Executives
10.1.3 Company snapshot
10.1.4 Operating business segments
10.1.5 Product portfolio
10.1.6 Business performance
10.1.7 Key strategic moves and developments
10.2 Bio-Med Inc.
10.2.1 Company overview
10.2.2 Key Executives
10.2.3 Company snapshot
10.2.4 Operating business segments
10.2.5 Product portfolio
10.2.6 Business performance
10.2.7 Key strategic moves and developments
10.3 Dornier MedTech
10.3.1 Company overview
10.3.2 Key Executives
10.3.3 Company snapshot
10.3.4 Operating business segments
10.3.5 Product portfolio
10.3.6 Business performance
10.3.7 Key strategic moves and developments
10.4 KARL STORZ SE & Co. KG
10.4.1 Company overview
10.4.2 Key Executives
10.4.3 Company snapshot
10.4.4 Operating business segments
10.4.5 Product portfolio
10.4.6 Business performance
10.4.7 Key strategic moves and developments
10.5 Boston Scientific Corporation
10.5.1 Company overview
10.5.2 Key Executives
10.5.3 Company snapshot
10.5.4 Operating business segments
10.5.5 Product portfolio
10.5.6 Business performance
10.5.7 Key strategic moves and developments
10.6 BTL Industries
10.6.1 Company overview
10.6.2 Key Executives
10.6.3 Company snapshot
10.6.4 Operating business segments
10.6.5 Product portfolio
10.6.6 Business performance
10.6.7 Key strategic moves and developments
10.7 Shockwave Medical, Inc
10.7.1 Company overview
10.7.2 Key Executives
10.7.3 Company snapshot
10.7.4 Operating business segments
10.7.5 Product portfolio
10.7.6 Business performance
10.7.7 Key strategic moves and developments
10.8 SANUWAVE & SANUWAVE Health, Inc
10.8.1 Company overview
10.8.2 Key Executives
10.8.3 Company snapshot
10.8.4 Operating business segments
10.8.5 Product portfolio
10.8.6 Business performance
10.8.7 Key strategic moves and developments
10.9 Inceler Medikal Co. Ltd.
10.9.1 Company overview
10.9.2 Key Executives
10.9.3 Company snapshot
10.9.4 Operating business segments
10.9.5 Product portfolio
10.9.6 Business performance
10.9.7 Key strategic moves and developments
10.10 EMS Dolorclast
10.10.1 Company overview
10.10.2 Key Executives
10.10.3 Company snapshot
10.10.4 Operating business segments
10.10.5 Product portfolio
10.10.6 Business performance
10.10.7 Key strategic moves and developments
TABLE 1. GLOBAL SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 2. SHOCKWAVE THERAPY MARKET FOR ELECTROHYDRAULIC TECHNIQUE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 3. SHOCKWAVE THERAPY MARKET FOR PIEZOELECTRIC TECHNIQUE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 4. SHOCKWAVE THERAPY MARKET FOR RADIAL TECHNIQUE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 5. SHOCKWAVE THERAPY MARKET FOR ELECTROMAGNETIC SHOCK WAVES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 6. GLOBAL SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 7. SHOCKWAVE THERAPY MARKET FOR MOBILE SHOCKWAVE THERAPY DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 8. SHOCKWAVE THERAPY MARKET FOR FIXED SHOCKWAVE THERAPY DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 9. GLOBAL SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. SHOCKWAVE THERAPY MARKET FOR ORTHOPEDICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 11. SHOCKWAVE THERAPY MARKET FOR CARDIOLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 12. SHOCKWAVE THERAPY MARKET FOR UROLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 13. SHOCKWAVE THERAPY MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 14. GLOBAL SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 15. SHOCKWAVE THERAPY MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 16. SHOCKWAVE THERAPY MARKET FOR CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 17. SHOCKWAVE THERAPY MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 18. SHOCKWAVE THERAPY MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 19. NORTH AMERICA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 20. NORTH AMERICA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 21. NORTH AMERICA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 22. NORTH AMERICA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 23. NORTH AMERICA SHOCKWAVE THERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 24. U.S. SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 25. U.S. SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 26. U.S. SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 27. U.S. SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 28. CANADA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 29. CANADA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 30. CANADA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 31. CANADA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 32. MEXICO SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 33. MEXICO SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 34. MEXICO SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 35. MEXICO SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 36. EUROPE SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 37. EUROPE SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 38. EUROPE SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 39. EUROPE SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 40. EUROPE SHOCKWAVE THERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 41. GERMANY SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 42. GERMANY SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 43. GERMANY SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 44. GERMANY SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 45. FRANCE SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 46. FRANCE SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 47. FRANCE SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 48. FRANCE SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 49. UK SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 50. UK SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 51. UK SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 52. UK SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 53. ITALY SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 54. ITALY SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 55. ITALY SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 56. ITALY SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 57. SPAIN SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 58. SPAIN SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 59. SPAIN SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 60. SPAIN SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 61. REST OF EUROPE SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 62. REST OF EUROPE SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 63. REST OF EUROPE SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 64. REST OF EUROPE SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 65. ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 66. ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 67. ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 68. ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 69. ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 70. JAPAN SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 71. JAPAN SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 72. JAPAN SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 73. JAPAN SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 74. CHINA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 75. CHINA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 76. CHINA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 77. CHINA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 78. AUSTRALIA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 79. AUSTRALIA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 80. AUSTRALIA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 81. AUSTRALIA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 82. INDIA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 83. INDIA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 84. INDIA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 85. INDIA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 86. SOUTH KOREA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 87. SOUTH KOREA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 88. SOUTH KOREA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 89. SOUTH KOREA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 90. REST OF ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 91. REST OF ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 92. REST OF ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 93. REST OF ASIA-PACIFIC SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 94. LAMEA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 95. LAMEA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 96. LAMEA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 97. LAMEA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 98. LAMEA SHOCKWAVE THERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 99. BRAZIL SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 100. BRAZIL SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 101. BRAZIL SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 102. BRAZIL SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 103. SAUDI ARABIA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 104. SAUDI ARABIA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 105. SAUDI ARABIA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 106. SAUDI ARABIA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 107. SOUTH AFRICA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 108. SOUTH AFRICA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 109. SOUTH AFRICA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 110. SOUTH AFRICA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 111. REST OF LAMEA SHOCKWAVE THERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 112. REST OF LAMEA SHOCKWAVE THERAPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 113. REST OF LAMEA SHOCKWAVE THERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 114. REST OF LAMEA SHOCKWAVE THERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 115. EDAP TMS: KEY EXECUTIVES
TABLE 116. EDAP TMS: COMPANY SNAPSHOT
TABLE 117. EDAP TMS: OPERATING SEGMENTS
TABLE 118. EDAP TMS: PRODUCT PORTFOLIO
TABLE 119. EDAP TMS: NET SALES
TABLE 120. EDAP TMS: KEY STRATERGIES
TABLE 121. BIO-MED INC.: KEY EXECUTIVES
TABLE 122. BIO-MED INC.: COMPANY SNAPSHOT
TABLE 123. BIO-MED INC.: OPERATING SEGMENTS
TABLE 124. BIO-MED INC.: PRODUCT PORTFOLIO
TABLE 125. BIO-MED INC.: NET SALES
TABLE 126. BIO-MED INC.: KEY STRATERGIES
TABLE 127. DORNIER MEDTECH: KEY EXECUTIVES
TABLE 128. DORNIER MEDTECH: COMPANY SNAPSHOT
TABLE 129. DORNIER MEDTECH: OPERATING SEGMENTS
TABLE 130. DORNIER MEDTECH: PRODUCT PORTFOLIO
TABLE 131. DORNIER MEDTECH: NET SALES
TABLE 132. DORNIER MEDTECH: KEY STRATERGIES
TABLE 133. KARL STORZ SE & CO. KG: KEY EXECUTIVES
TABLE 134. KARL STORZ SE & CO. KG: COMPANY SNAPSHOT
TABLE 135. KARL STORZ SE & CO. KG: OPERATING SEGMENTS
TABLE 136. KARL STORZ SE & CO. KG: PRODUCT PORTFOLIO
TABLE 137. KARL STORZ SE & CO. KG: NET SALES
TABLE 138. KARL STORZ SE & CO. KG: KEY STRATERGIES
TABLE 139. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 140. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 141. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 142. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 143. BOSTON SCIENTIFIC CORPORATION: NET SALES
TABLE 144. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 145. BTL INDUSTRIES: KEY EXECUTIVES
TABLE 146. BTL INDUSTRIES: COMPANY SNAPSHOT
TABLE 147. BTL INDUSTRIES: OPERATING SEGMENTS
TABLE 148. BTL INDUSTRIES: PRODUCT PORTFOLIO
TABLE 149. BTL INDUSTRIES: NET SALES
TABLE 150. BTL INDUSTRIES: KEY STRATERGIES
TABLE 151. SHOCKWAVE MEDICAL, INC: KEY EXECUTIVES
TABLE 152. SHOCKWAVE MEDICAL, INC: COMPANY SNAPSHOT
TABLE 153. SHOCKWAVE MEDICAL, INC: OPERATING SEGMENTS
TABLE 154. SHOCKWAVE MEDICAL, INC: PRODUCT PORTFOLIO
TABLE 155. SHOCKWAVE MEDICAL, INC: NET SALES
TABLE 156. SHOCKWAVE MEDICAL, INC: KEY STRATERGIES
TABLE 157. SANUWAVE & SANUWAVE HEALTH, INC: KEY EXECUTIVES
TABLE 158. SANUWAVE & SANUWAVE HEALTH, INC: COMPANY SNAPSHOT
TABLE 159. SANUWAVE & SANUWAVE HEALTH, INC: OPERATING SEGMENTS
TABLE 160. SANUWAVE & SANUWAVE HEALTH, INC: PRODUCT PORTFOLIO
TABLE 161. SANUWAVE & SANUWAVE HEALTH, INC: NET SALES
TABLE 162. SANUWAVE & SANUWAVE HEALTH, INC: KEY STRATERGIES
TABLE 163. INCELER MEDIKAL CO. LTD.: KEY EXECUTIVES
TABLE 164. INCELER MEDIKAL CO. LTD.: COMPANY SNAPSHOT
TABLE 165. INCELER MEDIKAL CO. LTD.: OPERATING SEGMENTS
TABLE 166. INCELER MEDIKAL CO. LTD.: PRODUCT PORTFOLIO
TABLE 167. INCELER MEDIKAL CO. LTD.: NET SALES
TABLE 168. INCELER MEDIKAL CO. LTD.: KEY STRATERGIES
TABLE 169. EMS DOLORCLAST: KEY EXECUTIVES
TABLE 170. EMS DOLORCLAST: COMPANY SNAPSHOT
TABLE 171. EMS DOLORCLAST: OPERATING SEGMENTS
TABLE 172. EMS DOLORCLAST: PRODUCT PORTFOLIO
TABLE 173. EMS DOLORCLAST: NET SALES
TABLE 174. EMS DOLORCLAST: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
